首页>
外国专利>
EMERGENCY KIT self and mutual acute stroke
EMERGENCY KIT self and mutual acute stroke
展开▼
机译:急救箱自我和相互急性中风
展开▼
页面导航
摘要
著录项
相似文献
摘要
1.u0430u043fu0435u0442u0447u043au0430, u0441u043eu0434u0435u0440u0436u0430u0449u0430u00a0 u0444u0443u0442u043bu00a0u0440, u0443u043fu043eu0440u00a0u0434u043eu0447u0435u043du043du043e located therein a set of medical means and instructions for use of the kit with an algorithm for medication and u043du0435u043eu0442u043bu043eu0436 of action, located on the walls of u0444u0443u0442u043bu00a0u0440u0430, u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0, set of medical means contains no more than three ", including the maximum one-time tera u043fu0435u0432u0442u0438u0447u0435u0441u043au0438u0445 doses at leastthe two drugs u0446u0438u0442u043eu043fu0440u043eu0442u0435u043au0442u0438u0432u043du044bu043c enhances the survival of cells and tissue injury, but the different mechanism of with all medicines, entrance u00a0u0449u0438u0435 set designed and provide emergency self and mutual assistance with acute disorder of brain u043au0440u043eu0432u043eu043eu0431u0440u0430u0449u0435u043du0438u00a0.;2. kit for u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0 1, so that a drug with u0446u0438u0442u043eu043fu0440u043eu0442u0435u043au0442u0438u0432u043du044bu043c enhances the survival of cells and brain tissue of has the product miniaturization excessive intake of u043au0430u043bu044cu0446u0438u00a0 in vascular cells and brain tissue.;3. kit for u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0 2, so that a drug u0443u043cu0435u043du044cu0448u0430u044eu0449u0435u0433u043e excess input u043au0430u043bu044cu0446u0438u00a0 in vascular cells and brain tissue has u0430u043du0442u043eu0433u043eu043du0438u0441u0442 u0433u043bu0443u0442u0430u043cu0430u0442u043du044b x receptor and / or u0430u043du0442u043eu0433u043eu043du0438u0441u0442 u043fu043eu0442u0435u043du0446u0438u0430u043bu0437u0430u0432u0438u0441u0438u043cu044bu0445 calcium channels and / or inhibitor synthesis and u043fu0440u0435u0441u0438u043du0430u043fu0442u0438u0447u0435u0441u043au043eu0433u043e u0432u044bu0441u0432u043eu0431u043eu0436u0434u0435u043du0438u00a0 u0433u043bu0443u0442u0430u043cu0430u0442u0430.;4. kit for u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0 3, so that a u0430u043du0442u043eu0433u043eu043du0438u0441u0442u0430 u0433u043bu0443u0442u0430u043cu0430u0442u043du044bu0445 receptors is the u043cu0430u0433u043du0438u00a0 and / or u0440u0435u043cu0430u0446u0435u043cu0438u0434.;5. kit for p.4, u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0, as drug u043cu0430u0433u043du0438u00a0 has u0440u0430u0441u0442u0432u043eu0440u0438u043cu043eu0435 connection u043cu0430u0433u043du0438u00a0, for example u043cu0430u0433u043du0438u00a0 u043eu0440u043eu0442u0430u0442, u043cu0430u0433u043du0438u00a0 citrate, u043cu0430u0433u043du0438u00a0 lactate or other soluble s u0441u043eu0435u0434u0438u043du0435u043du0438u00a0 u043cu0430u0433u043du0438u00a0 and their combination, as well as u043cu0430u0433u043du0438u00a0 u0440u0430u0441u0442u0432u043eu0440u0438u043cu043eu0435 compound in combination with other biologically active substances, for example, magne - b6 (u043au043eu043cu043fu043bu0435u043au0441u043du044b in the drug containing u043cu0430u0433u043du0438u00a0 lactate u0434u0438u0433u0438u0434u0440u0430u0442, u043cu0430u0433u043du0438u00a0 u043fu0438u0434u043eu043bu0430u0442,u043fu0438u0440u0438u0434u043eu043au0441u0438u043du0430 hydrochloride), u043fu0430u043du0430u043du0433u0438u043d or u0430u0441u043fu0430u0440u043au0430u043c (integrated drug containing u043cu0430u0433u043du0438u00a0 and u043au0430u043bu0438u00a0 u0430u0441u043fu0430u0440u0430u0433u0438u043du0430u0442) and other integrated products containing magnesium.;6. kit for 2, u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0, as inhibitors of synthesis and u043fu0440u0435u0441u0438u043du0430u043fu0442u0438u0447u0435u0441u043au043eu0433u043e u0432u044bu0441u0432u043eu0431u043eu0436u0434u0435u043du0438u00a0 u0433u043bu0443u0442u0430u043cu0430u0442u0430 has the drug itself u043bu0443u0431u0435u043bu0443u0437u043eu043b.;7. kit for u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0 2, so that a u0430u043du0442u043eu0433u043eu043du0438u0441u0442u0430 u043fu043eu0442u0435u043du0446u0438u0430u043bu0437u0430u0432u0438u0441u0438u043cu044bu0445 calcium channels is the drug itself nimodipine.;8. kit for u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0 1, so that a drug with u0446u0438u0442u043eu043fu0440u043eu0442u0435u043au0442u0438u0432u043du044bu043c enhances the survival of cells and brain tissue of a brake is not u0439u0440u043eu0442u0440u0430u043du0441u043cu0438u0441u0441u0438u0438 e.g. amino acids glycine and / or medicine, raising the level of gama - u0430u043cu0438u043du043eu043cu0430u0441u043bu00a0u043du043du043eu0439 acid such as u043au043bu043eu043cu0435u0442u0438u0430u0437u043eu043b.;9. kit for u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0 1, so that a drug with u0446u0438u0442u043eu043fu0440u043eu0442u0435u043au0442u0438u0432u043du044bu043c enhances the survival of cells and tissues of the brain has to u043du043eu043eu0442u0440u043eu043fu043du044bu043c the action.;10. kit for u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0 p.9, however, as a substance with u043du043eu043eu0442u0440u043eu043fu043du044bu043c action is a synthetic analogue of the u0430u0434u0440u0435u043du043eu043au043eu0440u0442u0438u043au043eu0442u0440u043e u0433u0435u043fu0442u0430u043fu0435u043fu0442u0438u0434, u00a0u0432u043bu00a0u044eu0449u0438u0439u0441u00a0 u043fu043du043eu0433u043e hormone - u043cu0435u0442u0438u043eu043du0438u043b - u0433u043bu0443u0442u0430u043cu0438u043b - u0433u0438u0441u0442u0438u0434u0438u043b - u0444u0435u043du0438u043bu0438u0430u043bu0430u043du0438u043b - shed - u0433u043bu0438u0446u0438u043b - proline under the trade name u0441u0435u043cu0430u043au0441 and / or officinalis drug piracetam and / or u0445u043eu043bu0438u043du0430 al u044cu0444u043eu0441u0446u0435u0440u0430u0442 under the trade name u0433u043bu0438u0430u0442u0438u043bu0438u043d.;11. kit for u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0 1, so that a drug with u0446u0438u0442u043eu043fu0440u043eu0442u0435u043au0442u0438u0432u043du044bu043c enhances the survival of cells and tissues of the brain has to u0430u043du0442u0438u043eu043au0441u0438u0434u0430u043d u0442u043du044bu043c and / or u0430u043du0442u0438u0433u0438u043fu043eu043au0441u0430u043du0442u043du044bu043c effects.;12. kit for u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0 p.11, however, as a substance with (and / or u0430u043du0442u0438u0433u0438u043fu043eu043au0441u0430u043du0442u043du044bu043c effects is the drug itself u044du0442u0438u043bu043cu0435u0442u0438u043bu0433u0438u0434u0440u043eu043au0441u0438u043fu0438u0440u0438 dean u0441u0443u043au0446u0438u043du0430u0442 under u0442u043eu0440u0433u043eu0432u044cu043c called u043cu0435u043au0441u0438u043au043eu0440 and u043cu0435u043au0441u0438u0434u043eu043b or drug itself u0434u0438u043cu0435u0444u043eu0441u0444u043eu043d or blocker synthesis oxide substance containing selenium, nap remer u044du0431u0441u0435u043bu0435u043d or selenium fort or u0442u0440u0438u043eu0432u0438u0442.;13. kit for u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0 1, so that a drug with u0446u0438u0442u043eu043fu0440u043eu0442u0435u043au0442u0438u0432u043du044bu043c enhances the survival of cells and brain tissue by improving is the mo u0437u0433u043eu0432u043eu0435 circulation.;14. kit for u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0 p.13, however, as the drug u0443u043bu0443u0447u0448u0430u044eu0449u0435u0433u043e brain blood circulation contains vinpocetine or u043du0438u0446u0435u0440u043eu0433u043bu0438u043d or cinnarizine or u0430u043cu0438u043du043eu0444u0438u043bu043bu0438u043d or u043du0438u043au043eu0442u0438u043du043eu0438u043b gamma u0430u043cu0438u043du043eu043cu0430u0441u043bu00a0u043du0430u00a0 acid under u0442u043eu0440u0433u043eu0432u044cu043c called picamilon.;15. kit for u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0 1, so that a drug with u0446u0438u0442u043eu043fu0440u043eu0442u0435u043au0442u0438u0432u043du044bu043c enhances the survival of cells and brain tissue of has u043fu043eu043bu0438u043au043eu043cu043fu043eu043du0435u043du0442u043du044bu0439 tea aratus u0446u0435u0440u0435u0431u0440u0430u043b or u0430u043au0442u043eu0432u0435u0433u0438u043d or fibroblast growth factors.;16. kit for u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0 1, so that a set of medicinal products is further introduced to u0433u0438u043fu043eu0442u0435u043du0437u0438u0432u043du044bu043c drug effects, such as u0430u043du0433u0438u043eu0442u0435u043du0437u0438u043du043fu0440u0435u0432u0440u0430u0449u0430u044eu0449u0435u0433 blocker the enzyme captopril or u044du043du0430u043bu043eu043fu0440u0438u043b or u043au0432u0438u043du0430u043fu0440u0438u043b or perindopril and calcium channel blocker, nifedipine.;17. kit for u043eu0442u043bu0438u0447u0430u044eu0449u0430u00a0u0441u00a0 1, so that a set of medical means further introduced the miniaturization of dizziness, nausea and vomiting, for example officinalis p u0440u0435u043fu0430u0440u0430u0442 betahistine or aeron or u0442u043eu0440u0435u043au0430u043d.
展开▼